苏桃-广州中医药大学中药学院（新）

药剂学学部

苏桃

研究员，博士生导师，博士后合作导师。

以第一/通讯作者在Advanced Science, Acta Pharmaceutica Sinica B, Pharmacological Research等杂志发表SCl论文40篇，申请/授权专利9项，获优秀毕业论文指导老师等奖励5项。连续三年指导研究生获“国家奖学金”、“优秀毕业生”等称号。兼任中华中医药学会粤港澳青年中医药传承创新研讨会副主任委员，广东省药理学会中药药理专业委员会常务委员等。入选广东省青年珠江学者，中华中医药学会青年托举人才。

E-mail：sutao@gzucm.edu.cn

教育工作经历

2012年、2016年分别获得南京中医药大学硕士学位和香港浸会大学博士学位，之后继续在香港浸会大学从事博士后研究工作。2017年12月以“杏林青年学者”引进至广州中医药大学中药学院。

研究方向

1）肿瘤发病机制及治疗靶点发现研究

2）中药抗肿瘤药理研究

3）中药炮制机理研究

科研及教学课题

1.国家自然科学基金面上项目，82274158，2023.1.1-2026.12.31，52万元，主持。

2.国家自然科学基金面上项目，82074019，2021.01- 2024.12，55万元，主持。

3.国家自然科学基金青年项目，81703705，2018.01-2020.12，20万元，主持。

4.广东省青年珠江学者，中药学，2024.10.1-2027.9.30，100万，主持。

5.广东省科技厅，中医药广东省实验室培植项目，HQL2024PZ042，2024.9.1-2026.8.31，120万，主持。

6.省部共建中医湿证国家重点实验室揭榜挂帅开放课题重点项目，SZ2024KF02，2025.1.1-2025.12.31，50万，主持。

7.广州市基础与应用基础研究专题优秀博士“续航”项目，2025A04J5398，2025.1.1-2026.12.31，10万，主持。

8.广州中医药大学青年拔尖人才（团队）培育“揭榜挂帅”项目，2023.9-2026.9，25万元，主持。

9.中华中医药学会，青年人才托举工程项目，2021-QNRC2-B15, 2022.1.1-2024.12.31，在研，主持。

10.广东省普通高校特色创新类项目, 2020KTSCX030，2021.1-2022.12，10万元，主持。

承担课程

主要承担《中药学导论》、《中药炮制学》、《科研基础训练》、《药学专论》等课程。

代表性研究论文

1. Fan XY, Li BT, Zhang F, Liu M, Hiu HY, Liu ZQ, Su T*. FGF19-activated hepatic stellate cells release ANGPTL4 that pPromotes colorectal cancer liver metastasis, Advanced Science. 2025,12(7):e2413525. (中科院1区，IF：14.1)

2. Liu YY, Zhang ZR, Li XY, H QH, Lv J, Xue JY, Wang DY, Cao JX, Li LY, Ou XW, Zhu ZJ, Liu ZQ, Su T. Wogonin effects on the efflux transporters BCRP and MRP2, explain its effectiveness in ulcerative colitis: implications for metabolic and transport interactions, Pharmacological Research, 2025, 212:107570. (中科院1区，IF：10.5)

3. Su T^#, Huang SC^#, Zhang YM, Guo YJ, Zhang SW, Guan JJ, Meng MJ, Liu LX, Wang CY, Yu DH, Kwan HY, Huang ZY, Huang QJ, Leung LH, Hu M, Wang Y, Liu ZQ, Lu LL. miR-7/TGF-β2 axis sustains acidic tumor microenvironment-induced lung cancer metastasis. Acta Pharmaceutica Sinica B, 2022, 12(2):821-837. (中科院1区，IF：14.9)

4. Su T, Shi ZQ, Tan JC, Liu LS, Zhao BQ, Fan XY, Wang CY, Kwan HY, Liu ZQ*. Casticin activates Rheb GTPase by binding to residue Trp141 and induces tumor senescence, Pharmacological Research, 2025, 218:107855. (中科院1区，IF：10.5)

5. Shi ZQ^#, Zeng HY^#, Zhao BQ, Zeng C, Fan Zhang F, Liu ZQ, Kwan HY, Su T*. Sulforaphane reverses the enhanced NSCLC metastasis by regulating the miR-7-5p/c-Myc/LDHA axis in the acidic tumor microenvironment. Phytomedicine. 2024, 133: 155874-155886. (中科院1区，IF：8.3)

6. Zhang F^#, Gan S^#, Liao JJ, Ting Jiang T, Shi ZQ, Fan XY, Kwan HY, Liu ZQ, Su T*. Single-cell RNA sequencing reveals the changes of the pulmonary immune environment in rat after Siegesbeckia orientalis L. treatment. Journal of Pharmaceutical Analysis. 2024, 14:101035-101038. (中科院1区，IF：8.9)

7. Chen MT, Zhong KY, Tan JC, Meng MJ, Liu CM, Chen BS, Huang CH, Wong HLX, Bian ZX, Su T, Kwan HY. Baicalein is a novel TLR4-targeting therapeutics agent that inhibits TLR4/HIF-1α/VEGF signaling pathway in colorectal cancer. Clin Transl Med. 2021, 11(11):e564.11.492. (中科院1区，IF：6.8)

8. Su T^#, Huang CH^#, Yang CF, Jiang T, Su JF, Chen MT, Fatima S, Gong RH, Hu XJ, Bian ZX, Liu ZQ, Kwan HY*. Apigenin inhibits STAT3/CD36 signaling axis and reduces visceral obesity, Pharmacological Research, 2020, 152: 104586. (中科院1区，IF：10.5)

9. Fan XY^#, Meng MJ^#, Li BT, Chen H, Tan JC, Xu KY, Xiao SL, Kwan HY, Liu ZQ, Su T*. Brevilin A is a potent anti-metastatic CRC agent that targets the VEGF-IL6-STAT3 axis in the HSCs-CRC interplay. Journal of Translational Medicine, 2023, 21: 260. (中科院2区，IF：7.5)

10. An L, Zhang M, Lin YF, Jiang T, Xu KY, Xiao SL, Cai LM, Kwan HY, Liu ZQ, Su T*. Morroniside, a novel GATA3 binding molecule, inhibits hepatic stellate cells activation by enhancing lysosomal acid lipase expression. Phytomedicine, 2022, 103, 154199. (中科院1区，IF：8.3)

上一条：李思怡

下一条：王术玲

首页

学院概况

师资队伍

科学研究

人才培养

学生工作

合作交流

党建工会

资源下载

特色文化资源库

最新推荐

苏桃

教育工作经历

研究方向

科研及教学课题

承担课程

代表性研究论文

1. Fan XY, Li BT, Zhang F, Liu M, Hiu HY, Liu ZQ, Su T*. FGF19-activated hepatic stellate cells release ANGPTL4 that pPromotes colorectal cancer liver metastasis, Advanced Science. 2025,12(7):e2413525. (中科院1区，IF：14.1)

4. Su T, Shi ZQ, Tan JC, Liu LS, Zhao BQ, Fan XY, Wang CY, Kwan HY, Liu ZQ*. Casticin activates Rheb GTPase by binding to residue Trp141 and induces tumor senescence, Pharmacological Research, 2025, 218:107855. (中科院1区，IF：10.5)

5. Shi ZQ^#, Zeng HY^#, Zhao BQ, Zeng C, Fan Zhang F, Liu ZQ, Kwan HY, Su T*. Sulforaphane reverses the enhanced NSCLC metastasis by regulating the miR-7-5p/c-Myc/LDHA axis in the acidic tumor microenvironment. Phytomedicine. 2024, 133: 155874-155886. (中科院1区，IF：8.3)

7. Chen MT, Zhong KY, Tan JC, Meng MJ, Liu CM, Chen BS, Huang CH, Wong HLX, Bian ZX, Su T, Kwan HY. Baicalein is a novel TLR4-targeting therapeutics agent that inhibits TLR4/HIF-1α/VEGF signaling pathway in colorectal cancer. Clin Transl Med. 2021, 11(11):e564.11.492. (中科院1区，IF：6.8)

8. Su T^#, Huang CH^#, Yang CF, Jiang T, Su JF, Chen MT, Fatima S, Gong RH, Hu XJ, Bian ZX, Liu ZQ, Kwan HY*. Apigenin inhibits STAT3/CD36 signaling axis and reduces visceral obesity, Pharmacological Research, 2020, 152: 104586. (中科院1区，IF：10.5)

9. Fan XY^#, Meng MJ^#, Li BT, Chen H, Tan JC, Xu KY, Xiao SL, Kwan HY, Liu ZQ, Su T*. Brevilin A is a potent anti-metastatic CRC agent that targets the VEGF-IL6-STAT3 axis in the HSCs-CRC interplay. Journal of Translational Medicine, 2023, 21: 260. (中科院2区，IF：7.5)

10. An L, Zhang M, Lin YF, Jiang T, Xu KY, Xiao SL, Cai LM, Kwan HY, Liu ZQ, Su T*. Morroniside, a novel GATA3 binding molecule, inhibits hepatic stellate cells activation by enhancing lysosomal acid lipase expression. Phytomedicine, 2022, 103, 154199. (中科院1区，IF：8.3)

友情链接

最新推荐

苏桃

教育工作经历

研究方向

科研及教学课题

承担课程

代表性研究论文

1. Fan XY, Li BT, Zhang F, Liu M, Hiu HY*, Liu ZQ*, Su T*. FGF19-activated hepatic stellate cells release ANGPTL4 that pPromotes colorectal cancer liver metastasis, Advanced Science. 2025,12(7):e2413525. (中科院1区，IF：14.1)

4. Su T, Shi ZQ, Tan JC, Liu LS, Zhao BQ, Fan XY, Wang CY*, Kwan HY*, Liu ZQ*. Casticin activates Rheb GTPase by binding to residue Trp141 and induces tumor senescence, Pharmacological Research, 2025, 218:107855. (中科院1区，IF：10.5)

5. Shi ZQ#, Zeng HY#, Zhao BQ, Zeng C, Fan Zhang F, Liu ZQ*, Kwan HY*, Su T*. Sulforaphane reverses the enhanced NSCLC metastasis by regulating the miR-7-5p/c-Myc/LDHA axis in the acidic tumor microenvironment. Phytomedicine. 2024, 133: 155874-155886. (中科院1区，IF：8.3)

7. Chen MT, Zhong KY, Tan JC, Meng MJ, Liu CM, Chen BS, Huang CH, Wong HLX, Bian ZX, Su T*, Kwan HY*. Baicalein is a novel TLR4-targeting therapeutics agent that inhibits TLR4/HIF-1α/VEGF signaling pathway in colorectal cancer. Clin Transl Med. 2021, 11(11):e564.11.492. (中科院1区，IF：6.8)

8. Su T#, Huang CH#, Yang CF, Jiang T, Su JF, Chen MT, Fatima S, Gong RH, Hu XJ, Bian ZX*, Liu ZQ*, Kwan HY*. Apigenin inhibits STAT3/CD36 signaling axis and reduces visceral obesity, Pharmacological Research, 2020, 152: 104586. (中科院1区，IF：10.5)

9. Fan XY#, Meng MJ#, Li BT, Chen H, Tan JC, Xu KY, Xiao SL, Kwan HY*, Liu ZQ*, Su T*. Brevilin A is a potent anti-metastatic CRC agent that targets the VEGF-IL6-STAT3 axis in the HSCs-CRC interplay. Journal of Translational Medicine, 2023, 21: 260. (中科院2区，IF：7.5)

10. An L, Zhang M, Lin YF, Jiang T, Xu KY, Xiao SL, Cai LM, Kwan HY*, Liu ZQ*, Su T*. Morroniside, a novel GATA3 binding molecule, inhibits hepatic stellate cells activation by enhancing lysosomal acid lipase expression. Phytomedicine, 2022, 103, 154199. (中科院1区，IF：8.3)

友情链接

1. Fan XY, Li BT, Zhang F, Liu M, Hiu HY, Liu ZQ, Su T*. FGF19-activated hepatic stellate cells release ANGPTL4 that pPromotes colorectal cancer liver metastasis, Advanced Science. 2025,12(7):e2413525. (中科院1区，IF：14.1)

4. Su T, Shi ZQ, Tan JC, Liu LS, Zhao BQ, Fan XY, Wang CY, Kwan HY, Liu ZQ*. Casticin activates Rheb GTPase by binding to residue Trp141 and induces tumor senescence, Pharmacological Research, 2025, 218:107855. (中科院1区，IF：10.5)

5. Shi ZQ^#, Zeng HY^#, Zhao BQ, Zeng C, Fan Zhang F, Liu ZQ, Kwan HY, Su T*. Sulforaphane reverses the enhanced NSCLC metastasis by regulating the miR-7-5p/c-Myc/LDHA axis in the acidic tumor microenvironment. Phytomedicine. 2024, 133: 155874-155886. (中科院1区，IF：8.3)

7. Chen MT, Zhong KY, Tan JC, Meng MJ, Liu CM, Chen BS, Huang CH, Wong HLX, Bian ZX, Su T, Kwan HY. Baicalein is a novel TLR4-targeting therapeutics agent that inhibits TLR4/HIF-1α/VEGF signaling pathway in colorectal cancer. Clin Transl Med. 2021, 11(11):e564.11.492. (中科院1区，IF：6.8)

8. Su T^#, Huang CH^#, Yang CF, Jiang T, Su JF, Chen MT, Fatima S, Gong RH, Hu XJ, Bian ZX, Liu ZQ, Kwan HY*. Apigenin inhibits STAT3/CD36 signaling axis and reduces visceral obesity, Pharmacological Research, 2020, 152: 104586. (中科院1区，IF：10.5)

9. Fan XY^#, Meng MJ^#, Li BT, Chen H, Tan JC, Xu KY, Xiao SL, Kwan HY, Liu ZQ, Su T*. Brevilin A is a potent anti-metastatic CRC agent that targets the VEGF-IL6-STAT3 axis in the HSCs-CRC interplay. Journal of Translational Medicine, 2023, 21: 260. (中科院2区，IF：7.5)

10. An L, Zhang M, Lin YF, Jiang T, Xu KY, Xiao SL, Cai LM, Kwan HY, Liu ZQ, Su T*. Morroniside, a novel GATA3 binding molecule, inhibits hepatic stellate cells activation by enhancing lysosomal acid lipase expression. Phytomedicine, 2022, 103, 154199. (中科院1区，IF：8.3)